{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:10:08Z","timestamp":1788307808706,"version":"build-2803163510"},"reference-count":57,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,1]]},"abstract":"<jats:p>Objective. The issue of thimerosal-containing vaccines as a possible cause of autistic spectrum disorders (ASD) and neurodevelopmental disorders (NDDs) has been a controversial topic since 1999. Although most practitioners are familiar with the controversy, many are not familiar with the type or quality of evidence in published articles that have addressed this issue. To assess the quality of evidence assessing a potential association between thimerosal-containing vaccines and autism and evaluate whether that evidence suggests accepting or rejecting the hypothesis, we systematically reviewed published articles that report original data pertinent to the potential association between thimerosal-containing vaccines and ASD\/NDDs.<\/jats:p>\n               <jats:p>Methods. Articles for analysis were identified in the National Library of Medicine's Medline database using a PubMed search of the English-language literature for articles published between 1966 and 2004, using keywords thimerosal, thiomersal, mercury, methylmercury, or ethylmercury alone and combined with keywords autistic disorder, autistic spectrum disorder, and neurodevelopment. In addition, we used the \u201crelated links\u201d option in PubMed and reviewed the reference sections in the identified articles. All original articles that evaluated an association between thimerosal-containing vaccines and ASD\/NDDs or pharmacokinetics of ethylmercury in vaccines were included.<\/jats:p>\n               <jats:p>Results. Twelve publications that met the selection criteria were identified by the literature search: 10 epidemiologic studies and 2 pharmacokinetic studies of ethylmercury. The design and quality of the studies showed significant variation. The preponderance of epidemiologic evidence does not support an association between thimerosal-containing vaccines and ASD. Epidemiologic studies that support an association are of poor quality and cannot be interpreted. Pharmacokinetic studies suggest that the half-life of ethylmercury is significantly shorter when compared with methylmercury.<\/jats:p>\n               <jats:p>Conclusions. Studies do not demonstrate a link between thimerosal-containing vaccines and ASD, and the pharmacokinetics of ethylmercury make such an association less likely. Epidemiologic studies that support a link demonstrated significant design flaws that invalidate their conclusions. Evidence does not support a change in the standard of practice with regard to administration of thimerosal-containing vaccines in areas of the world where they are used.<\/jats:p>","DOI":"10.1542\/peds.2004-0434","type":"journal-article","created":{"date-parts":[[2004,11,5]],"date-time":"2004-11-05T17:23:17Z","timestamp":1099675397000},"page":"793-804","source":"Crossref","is-referenced-by-count":162,"title":["Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data"],"prefix":"10.1542","volume":"114","author":[{"given":"Sarah K.","family":"Parker","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children's Hospital and University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schwartz","sequence":"additional","affiliation":[{"name":"National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Todd","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital and University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry K.","family":"Pickering","sequence":"additional","affiliation":[{"name":"National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2004,9,1]]},"reference":[{"key":"2021121105453400700_R1","doi-asserted-by":"crossref","unstructured":"Halsey NA, Hyman SL. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12\u201313, 2000. Pediatrics.\u20082001;107(5). Available at: www.pediatrics.org\/cgi\/content\/full\/107\/5\/e84","DOI":"10.1542\/peds.107.5.e84"},{"key":"2021121105453400700_R2","doi-asserted-by":"crossref","unstructured":"Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA.\u20082001;285:1183\u20131185","DOI":"10.1001\/jama.285.9.1183"},{"key":"2021121105453400700_R3","doi-asserted-by":"crossref","unstructured":"Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics.\u20082001;108:1155\u20131161","DOI":"10.1542\/peds.108.5.1155"},{"key":"2021121105453400700_R4","doi-asserted-by":"crossref","unstructured":"Fombonne E. Is there an epidemic of autism?Pediatrics.\u20082001;107:411\u2013412","DOI":"10.1542\/peds.107.2.411"},{"key":"2021121105453400700_R5","doi-asserted-by":"crossref","unstructured":"Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA.\u20082001;285:3093\u20133099","DOI":"10.1001\/jama.285.24.3093"},{"key":"2021121105453400700_R6","doi-asserted-by":"crossref","unstructured":"Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord.\u20082002;32:207\u2013215","DOI":"10.1023\/A:1015453830880"},{"key":"2021121105453400700_R7","doi-asserted-by":"crossref","unstructured":"Gurney JG, Fritz MS, Ness KK, Sievers P, Newschaffer CJ, Shapiro EG. Analysis of prevalence trends of autism spectrum disorder in Minnesota. Arch Pediatr Adolesc Med.\u20082003;157:622\u2013627","DOI":"10.1001\/archpedi.157.7.622"},{"key":"2021121105453400700_R8","doi-asserted-by":"crossref","unstructured":"DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics.\u20082004;113:259\u2013266","DOI":"10.1542\/peds.113.2.259"},{"key":"2021121105453400700_R9","doi-asserted-by":"crossref","unstructured":"Lingam R, Simmons A, Andrews N, Miller E, Stowe J, Taylor B. Prevalence of autism and parentally reported triggers in a north east London population. Arch Dis Child.\u20082003;88:666\u2013670","DOI":"10.1136\/adc.88.8.666"},{"key":"2021121105453400700_R10","doi-asserted-by":"crossref","unstructured":"Rapin I. Autism. N Engl J Med.\u20081997;337:97\u2013104","DOI":"10.1056\/NEJM199707103370206"},{"key":"2021121105453400700_R11","doi-asserted-by":"crossref","unstructured":"Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses.\u20082001;56:462\u2013471","DOI":"10.1054\/mehy.2000.1281"},{"key":"2021121105453400700_R12","doi-asserted-by":"crossref","unstructured":"Bernard S, Enayati A, Roger H, Binstock T, Redwood L. The role of mercury in the pathogenesis of autism. Mol Psychiatry.\u20082002;7(suppl 2):S42\u2013S43","DOI":"10.1038\/sj.mp.4001177"},{"key":"2021121105453400700_R13","doi-asserted-by":"crossref","unstructured":"Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci.\u20082000;45:723\u2013729","DOI":"10.1023\/A:1005443726670"},{"key":"2021121105453400700_R14","doi-asserted-by":"crossref","unstructured":"Uhlmann V, Martin CM, Sheils O, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol.\u20082002;55:84\u201390","DOI":"10.1136\/mp.55.2.84"},{"key":"2021121105453400700_R15","doi-asserted-by":"crossref","unstructured":"Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet.\u20081998;351:637\u2013641","DOI":"10.1016\/S0140-6736(97)11096-0"},{"key":"2021121105453400700_R16","unstructured":"Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev.\u20082000;19:265\u2013283; discussion 284\u2013292"},{"key":"2021121105453400700_R17","unstructured":"US Environmental Protection Agency. Mercury study report to congress: volume IV: an assessment of exposure to mercury in the United States; 1997. Available at: www.epa.gov\/mercury"},{"key":"2021121105453400700_R18","doi-asserted-by":"crossref","unstructured":"Schober SE, Sinks TH, Jones RL, et al. Blood mercury levels in US children and women of childbearing age, 1999\u20132000. JAMA.\u20082003;289:1667\u20131674","DOI":"10.1001\/jama.289.13.1667"},{"key":"2021121105453400700_R19","unstructured":"National Academy of Sciences National Research Council Committee on the Toxicological Effects of Methylmercury. Toxicological Effects of Methylmercury. Washington, DC: National Academy Press; 2000"},{"key":"2021121105453400700_R20","unstructured":"United States Environmental Protection Agency. Mercury study report to congress: volume V: health effects of mercury and mercury compounds; 1997. Available at: www.epa.gov\/mercury"},{"key":"2021121105453400700_R21","doi-asserted-by":"crossref","unstructured":"Mahaffey KR. Recent advances in recognition of low-level methylmercury poisoning. Curr Opin Neurol.\u20082000;13:699\u2013707","DOI":"10.1097\/00019052-200012000-00015"},{"key":"2021121105453400700_R22","doi-asserted-by":"crossref","unstructured":"Dourson ML, Wullenweber AE, Poirier KA. Uncertainties in the reference dose for methylmercury. Neurotoxicology.\u20082001;22:677\u2013689","DOI":"10.1016\/S0161-813X(01)00060-2"},{"key":"2021121105453400700_R23","doi-asserted-by":"crossref","unstructured":"Magos L. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products. J Appl Toxicol.\u20082001;21:1\u20135","DOI":"10.1002\/jat.721"},{"key":"2021121105453400700_R24","doi-asserted-by":"crossref","unstructured":"Clarkson TW. The three modern faces of mercury. Environ Health Perspect.\u20082002;110(suppl 1):11\u201323","DOI":"10.1289\/ehp.02110s111"},{"key":"2021121105453400700_R25","doi-asserted-by":"crossref","unstructured":"Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med.\u20082003;349:1731\u20131737","DOI":"10.1056\/NEJMra022471"},{"key":"2021121105453400700_R26","doi-asserted-by":"crossref","unstructured":"Freed GL, Andreae MC, Cowan AE, Katz SL. The process of public policy formulation: the case of thimerosal in vaccines. Pediatrics.\u20082002;109:1153\u20131159","DOI":"10.1542\/peds.109.6.1153"},{"key":"2021121105453400700_R27","unstructured":"Food and Drug Administration. Thimerosal in Vaccines; 2003. Available at: www.fda.gov\/cber\/vaccine\/thimerosal.htm#1\/"},{"key":"2021121105453400700_R28","unstructured":"Stratton K, Gable A, Shetty P, et al. Report of the Institute of Medicine. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: National Academy Press; 2001"},{"key":"2021121105453400700_R29","doi-asserted-by":"crossref","unstructured":"Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med (Maywood).\u20082003;228:660\u2013664","DOI":"10.1177\/153537020322800603"},{"key":"2021121105453400700_R30","doi-asserted-by":"crossref","unstructured":"Geier DA, Geier MR. Thimerosal in childhood vaccines, neurodevelopmental disorders, and heart disease in the United States. J Am Phys Surg.\u20082003;8:6\u201311","DOI":"10.1080\/1363849031000139315"},{"key":"2021121105453400700_R31","doi-asserted-by":"crossref","unstructured":"Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil.\u20082003;6:97\u2013102","DOI":"10.1080\/1363849031000139315"},{"key":"2021121105453400700_R32","doi-asserted-by":"crossref","unstructured":"Verstraeten T, Davis RL, DeStefano F, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics.\u20082003;112:1039\u20131048","DOI":"10.1542\/peds.112.5.1039"},{"key":"2021121105453400700_R33","doi-asserted-by":"crossref","unstructured":"Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA.\u20082003;290:1763\u20131766","DOI":"10.1001\/jama.290.13.1763"},{"key":"2021121105453400700_R34","doi-asserted-by":"crossref","unstructured":"Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics.\u20082004;114:584\u2013591","DOI":"10.1542\/peds.2003-1177-L"},{"key":"2021121105453400700_R35","doi-asserted-by":"crossref","unstructured":"Heron J, Golding J, ALSPAC study team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics.\u20082004;114:577\u2013583","DOI":"10.1542\/peds.2003-1176-L"},{"key":"2021121105453400700_R36","doi-asserted-by":"crossref","unstructured":"Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med.\u20082003;25:101\u2013106","DOI":"10.1016\/S0749-3797(03)00113-2"},{"key":"2021121105453400700_R37","doi-asserted-by":"crossref","unstructured":"Madsen K, Lauritsen M, Pedersen C, et al. Thimerosal and the occurrence of autism? Negative ecological evidence from Danish population-based data. Pediatrics.\u20082003;112:604\u2013606","DOI":"10.1542\/peds.112.3.604"},{"key":"2021121105453400700_R38","doi-asserted-by":"crossref","unstructured":"Stajich GV, Lopez GP, Harry SW, Sexson WR. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr.\u20082000;136:679\u2013681","DOI":"10.1067\/mpd.2000.105133"},{"key":"2021121105453400700_R39","doi-asserted-by":"crossref","unstructured":"Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet.\u20082002;360:1737\u20131741","DOI":"10.1016\/S0140-6736(02)11682-5"},{"key":"2021121105453400700_R40","unstructured":"McCormick M, Bayer R, Berg A, et al. Report of the Institute of Medicine. Immunization Safety Review: Vaccines and Autism. Washington, DC: National Academy Press; 2004"},{"key":"2021121105453400700_R41","doi-asserted-by":"crossref","unstructured":"Redwood L, Bernard S, Brown D. Predicted mercury concentrations in hair from infant immunizations: cause for concern. Neurotoxicology.\u20082001;22:691\u2013697","DOI":"10.1016\/S0161-813X(01)00067-5"},{"key":"2021121105453400700_R42","doi-asserted-by":"crossref","unstructured":"Magos L. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. J Appl Toxicol.\u20082003;23:263\u2013269","DOI":"10.1002\/jat.918"},{"key":"2021121105453400700_R43","unstructured":"Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit.\u20082004;10:PI33\u2013PI39"},{"key":"2021121105453400700_R44","doi-asserted-by":"crossref","unstructured":"Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J.\u20082004;23:287\u2013294","DOI":"10.1097\/00006454-200404000-00002"},{"key":"2021121105453400700_R45","doi-asserted-by":"crossref","unstructured":"Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol.\u20082001;154:1006\u20131012","DOI":"10.1093\/aje\/154.11.1006"},{"key":"2021121105453400700_R46","doi-asserted-by":"crossref","unstructured":"Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health.\u20081995;85:1706\u20131709","DOI":"10.2105\/AJPH.85.12.1706"},{"key":"2021121105453400700_R47","doi-asserted-by":"crossref","unstructured":"Baird G, Charman T, Cox A, et al. Current topic: screening and surveillance of autism and pervasive developmental disorders. Arch Dis Child.\u20082001;84:468\u2013475","DOI":"10.1136\/adc.84.6.468"},{"key":"2021121105453400700_R48","unstructured":"Howlin P. Identifying and assessing children with autism or Asperger syndrome. In: Children With Autism and Asperger Syndrome: A Guide for Practitioners and Carers. West Sussex, UK: John Wiley and Sons Ltd; 1998:52\u201375"},{"key":"2021121105453400700_R49","unstructured":"Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001. MMWR Surveill Summ.\u20082003;52:1\u201324"},{"key":"2021121105453400700_R50","unstructured":"Verstraeten T, Davis R, DeStefano F. Thimerosal VSD study, phase I. Simpsonwood, GA; 2000. Available at: www.autisminfo.com\/GeneralResources.htm#S. Accessed July 5, 2003"},{"key":"2021121105453400700_R51","doi-asserted-by":"crossref","unstructured":"Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med.\u20082002;347:1477\u20131482","DOI":"10.1056\/NEJMoa021134"},{"key":"2021121105453400700_R52","unstructured":"Department of Education (US). Annual report to Congress on the implementation of the Individuals with Disabilities Education Act, 23rd annual report; 2001. Available at: www.ed.gov\/about\/reports\/annual\/osep\/2001\/index.html?exp=0:A-14"},{"key":"2021121105453400700_R53","unstructured":"Centers for Disease Control and Prevention. Live births my age of mother and race: United States, 1933\u201398. Available at: www.cdc.gov\/nchs\/data\/natality\/mage33tr.pdf. Accessed October 2003"},{"key":"2021121105453400700_R54","unstructured":"Burbacher TM, Clarkson TW. Mercury levels in blood and brain of infant monkeys exposed to thimerosal. Neurotoxicol Teratol.\u20082003;25:390 (abstr)"},{"key":"2021121105453400700_R55","doi-asserted-by":"crossref","unstructured":"Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol.\u20082003;22:277\u2013285","DOI":"10.1080\/10915810305120"},{"key":"2021121105453400700_R56","doi-asserted-by":"crossref","unstructured":"Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet.\u20081998;351:356\u2013361","DOI":"10.1016\/S0140-6736(97)04334-1"},{"key":"2021121105453400700_R57","doi-asserted-by":"crossref","unstructured":"Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science.\u20082003;301:804","DOI":"10.1126\/science.1086726"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/3\/793\/1027859\/zpe00904000793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/3\/793\/1027859\/zpe00904000793.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T09:00:45Z","timestamp":1639213245000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/114\/3\/793\/67190\/Thimerosal-Containing-Vaccines-and-Autistic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,1]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,9,1]]},"published-print":{"date-parts":[[2004,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-0434","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,1]]}}}